
Hofseth Biocare ASA ( ($HOFBF) ) has shared an update. Hofseth BioCare ASA published its financial calendar for financial years 2026 and 2027. The schedule lists the Q4 2026 quarterly
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| HOFBF | Hofseth Biocare ASA | 0.12 | -0.05 | -28.92% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.12 | -28.92% |

Hofseth Biocare ASA ( ($HOFBF) ) has shared an update. Hofseth BioCare ASA published its financial calendar for financial years 2026 and 2027. The schedule lists the Q4 2026 quarterly

Hofseth Biocare ASA ( ($HOFBF) ) just unveiled an update. HBC reported record third-quarter operating revenue of NOK 83.5 million, up from NOK 54.9 million a year earlier, while EBITDA

Hofseth Biocare ASA ( ($HOFBF) ) has issued an announcement. Hofseth BioCare ASA said its board approved a NOK 2,375 share-capital increase through the issuance of 237,500 ordinary shares. The

Hofseth Biocare ASA ( ($HOFBF) ) has issued an update. Hofseth BioCare ASA is a Norwegian consumer and pet health company focused on sustainable, traceable ingredients derived from salmon-industry side

Hofseth Biocare ASA ($HOFBF) announced an update on their ongoing clinical study. Hofseth Biocare ASA is preparing a new clinical trial to test whether a blend of whole salmon oil

Hofseth Biocare ASA ( ($HOFBF) ) just unveiled an update. Hofseth BioCare ASA, a Norwegian-listed producer of sustainable salmon-derived health ingredients for human and pet markets, continues to build its

Hofseth Biocare ASA ( ($HOFBF) ) has issued an announcement. Board member and primary insider Christoph Baldegger has increased his stake in Hofseth BioCare ASA with the purchase of 2.5

Hofseth Biocare ASA ($HOFBF) announced an update on their ongoing clinical study. The ProGo Menopause Wellbeing Study is a new trial led by Hofseth Biocare ASA to test whether its

Hofseth Biocare ASA ( ($HOFBF) ) has provided an update. Hofseth BioCare ASA has appointed long-serving executive Leif Arne Giske as its new Chief Financial Officer for the HBC Group,

Hofseth Biocare ASA ( ($HOFBF) ) has provided an update. Hofseth BioCare reported Q2 2026 operating revenue of NOK 65.7 million, slightly down year-on-year, but achieved this with about 44
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 12, 2027TBA | $61.07M | ― | ― | -0.51 | -3.88 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.